Patents by Inventor Catherine Cohen

Catherine Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inorganic/organic complexes for reducing skin irritation
    Publication number: 20030143252
    Abstract: &bgr;-Diketone/hydroxylated or carbonated activated cation inorganic/organic complexes are well suited for preventing, avoiding or reducing skin irritation, notably that elicited by exposure to irritant active agents/species or to the external environment.
    Type: Application
    Filed: December 30, 2002
    Publication date: July 31, 2003
    Inventors: Michel Philippe, Catherine Cohen
  • Inorganic/organic complexes for reducing skin irritation
    Patent number: 6521222
    Abstract: &bgr;-Diketone/hydroxylated or carbonated activated cation inorganic/organic complexes are well suited for reducing skin irritation, notably that elicited by exposure to irritant active agents/species or to the external environment.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: February 18, 2003
    Assignee: Societe L'Oreal S.A.
    Inventors: Michel Philippe, Catherine Cohen
  • Cosmetic, pharmaceutical or dermatological composition comprising a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist
    Publication number: 20010022978
    Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthesic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF-alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.
    Type: Application
    Filed: April 25, 2001
    Publication date: September 20, 2001
    Inventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen
  • Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF &agr;antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained
    Patent number: 6277387
    Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.
    Type: Grant
    Filed: September 8, 1999
    Date of Patent: August 21, 2001
    Assignee: L'Oreal
    Inventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen
  • Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition
    Patent number: 5993833
    Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1-antagonist and/or a TNF antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: November 30, 1999
    Assignee: Societe L'Oreal S.A.
    Inventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen
  • Salicyclic acid derivatives, process of preparation and uses thereof
    Patent number: 5917088
    Abstract: Novel salicylic acid derivatives, a process for their preparation and their use in a cosmetic or dermatological compositions.
    Type: Grant
    Filed: April 29, 1998
    Date of Patent: June 29, 1999
    Assignee: L'Oreal
    Inventors: Michel Philippe, Catherine Cohen
  • Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained
    Patent number: 5658581
    Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha anlagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 anlagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.
    Type: Grant
    Filed: December 28, 1995
    Date of Patent: August 19, 1997
    Assignee: L'Oreal
    Inventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen